Balaxi Pharmaceuticals (NSE:BALAXI) Long-Term Debt : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Long-Term Debt?

Balaxi Pharmaceuticals's Long-Term Debt for the quarter that ended in Dec. 2024 was ₹0 Mil.

Balaxi Pharmaceuticals's annual Long-Term Debt increased from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹9 Mil) but then declined from Mar. 2023 (₹9 Mil) to Mar. 2024 (₹0 Mil).

Balaxi Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Balaxi Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Long-Term Debt Chart

Balaxi Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

8.70

Balaxi Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Balaxi Pharmaceuticals (NSE:BALAXI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Balaxi Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Balaxi Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Balaxi Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 3rd Floor, Hyderabad, TG, IND, 500 096

Website

https://www.balaxipharma.in

Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Geographically it earns key revenue from Guatemala.

Balaxi Pharmaceuticals Headlines

No Headlines